GAUSS trial: investigational anti-PCSK9 antibody AMG145 significantly lowers LDL cholesterol in high-risk patients: http://www.internalmedicinenews.com/specialty-focus/cardiology/single-article-page/amg145-delivers-robust-results-for-statin-intolerant-patients.html …
1:17 PM - 5 Nov 2012
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.